Press Releases

Year

May 26, 2020

AnPac Bio Continues to Build Strong Patent Portfolio, with 3rd Patent Granted This Year in the United States

SAN JOSE, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that another new US

May 18, 2020

AnPac Files Its Annual Report on Form 20-F

SAN JOSE, Calif., May 18, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) (“AnPac Bio” or the “Company”), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that it has filed its annual

May 11, 2020

AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States

SAN JOSE, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance by the

Mar 27, 2020

AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists

SAN JOSE, Calif., March 27, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that its San Jose, CA lab

Mar 24, 2020

AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States

SAN JOSE, Calif. , March 24, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance by the

Feb 27, 2020

AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project

SAN JOSE, Calif. , Feb. 27, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has filed a

Feb 06, 2020

AnPac Bio Gains Two New Insurance Customers

SAN JOSE, Calif. , Feb. 6, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new

Jan 30, 2020

AnPac Bio Announces Pricing of Initial Public Offering

SAN JOSE, Calif. , Jan. 30, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its initial

Press Releases

Press Releases

Quick Links

Contact Information